Healthcare Services

Glycomics or Glycobiology Market Revenue Expected to Reach $4.66 Billion by 2030 with 17% CAGR

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Glycomics or Glycobiology Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The glycomics or glycobiology market has experienced rapid growth in recent years. It is forecast to grow from $2.13 billion in 2025 to $2.49 billion in 2026, at a compound annual growth rate (CAGR) of 17.1%. The historical expansion can be attributed to advances in carbohydrate chemistry, the growth of life sciences research, expansion of academic research funding, early biomolecule characterization, and the development of analytical instruments.

The glycomics or glycobiology market size is projected to experience significant expansion over the coming years. It is anticipated to reach $4.66 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.0%. This growth during the forecast period is attributable to several factors, including the expansion of precision medicine, substantial pharmaceutical R&D investments, a rising demand for biomarker discovery, ongoing technological advancements in mass spectrometry, and an increase in translational research. Key trends anticipated within the same period encompass the broadening of glycan-based biological research, an uptick in the application of glycomics for drug discovery, an increasing need for sophisticated glycan analysis tools, the growing incorporation of glycobiology into diagnostics, and heightened academic and industrial collaborations.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8749&type=smp

What Major Drivers Are Influencing Demand In The Glycomics or Glycobiology Market?

The rising need for pharmaceutical products is anticipated to advance the glycomics or glycobiology market’s expansion moving ahead. These products are medications or drugs specifically designed to identify, avert, alleviate, or heal illnesses or health issues in both humans and animals. glycomics and glycobiology play a crucial role in pharmaceutical development, offering understanding into disease processes, pinpointing treatment objectives, and enhancing the formulation and effectiveness of drugs for numerous medical ailments. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized treatments for individuals with rare diseases, marking an increase from six in 2022. Among the personalized treatments newly approved for 2023 were also seven drugs for cancer and three for other specific diseases and conditions. Consequently, the escalating demand for pharmaceutical products is fueling the expansion of the glycomics or glycobiology market.

What Major Segment Divisions Exist Within The Glycomics or Glycobiology Market?

The glycomics or glycobiology market covered in this report is segmented –

1) By Product: Enzymes, Kits, Reagents And Chemicals, Instruments, Carbohydrates

2) By Application: Drug Discovery And Development, Disease Diagnostics, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories

Subsegments:

1) By Enzymes: Glycosidases, Glycosyltransferases, Sialidases

2) By Kits: Glycan Analysis Kits, Glycobiology Research Kits

3) By Reagents And Chemicals: Monosaccharides, Oligosaccharides, Chemical Modifiers

4) By Instruments: Mass Spectrometers, Chromatography Systems, Imaging Systems

5) By Carbohydrates: Natural Carbohydrates, Synthetic Carbohydrates

What Major Market Trends Are Driving Changes In The Glycomics or Glycobiology Market?

Leading companies operating in the glycobiology market are focusing on developing innovative solutions, such as glycan-display platforms, to accelerate the discovery of carbohydrate-based therapeutics and vaccines. Glycan-display platforms are technologies that present diverse sugar molecules (glycans) on surfaces or scaffolds to study their interactions with proteins, cells, or pathogens for drug and vaccine development. For example, in October 2024, CD BioGlyco, a US-based biotechnology company, introduced its Glycan Display Platform. This advanced, integrated glycan-display technology provides multiple modalities (traditional glycan arrays, cell-based glycan display, neoglycolipid (NGL) display, liquid glycan arrays (LiGA), glyco-phage display, and de novo glycan display) that support a wide range of glycobiology research applications, including drug discovery and glycan-protein interaction studies. This platform uses synthesized or natural glycans and immobilizes or presents them on carriers like lipids, phage particles, or engineered cells, enabling researchers to explore glycan binding properties under various contexts (e.g., fluid versus immobilized, monovalent versus multivalent). Such capabilities facilitate high-throughput screening, precise control over glycan density or presentation format, and offer greater physiological relevance compared to traditional glycan microarrays, which typically immobilize glycans on rigid surfaces.

Which Companies Are Leading Innovation In The Glycomics or Glycobiology Market?

Major companies operating in the glycomics or glycobiology market are Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., R&D Systems Inc.

Read the full glycomics or glycobiology market report here:

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Glycomics or Glycobiology Market?

North America was the largest region in the glycomics or glycobiology market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Glycomics or Glycobiology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8749&type=smp

Browse Through More Reports Similar to the Global Glycomics or Glycobiology Market 2026, By The Business Research Company

Glycomics Or Glycobiology Global Market Report

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Glycopeptide Antibiotics Global Market Report

https://www.thebusinessresearchcompany.com/report/glycopeptide-antibiotics-global-market-report

Glycol Global Market Report

https://www.thebusinessresearchcompany.com/report/glycol-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795